Trial · NCT05696613
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in urinary protein (Phase 3a) | Change from baseline, months 1, 2, 3, 4, 5, 6, 9, and 12 | |
| Primary | Change in Anti-phospholipase A2 receptor (PLA2R) auto-antibody levels (Phase 3a) | Change from baseline, months 1, 2, 3, 4, 6, and 12 | |
| Primary | Complete response of PMN (Phase 3b) | 24 months | Reduction of proteinuria to ≤0.3 g/24 hours as measured by urine protein/creatinine ratio obtained from a 24-hour urine collection with stable renal function defined as a \<15% decline in eGFR at the time of endpoint assessment |
| Secondary | Relapse rate at month 12 and month 24. | 12 and 24 months | |
| Secondary | Anti-PLA2R (or Anti-THSD7A) auto-antibody levels. | 12 and 24 months | |
| Secondary | Estimated glomerular filtration rate (eGFR) with proteinuria levels. | 12 and 24 months | |
| Secondary | Adverse events | 24 months | |
| Secondary | Incidence of ADAs | 24 months | |
| Secondary | Number of patients who achieved a complete remission (CR) or partial remission (PR) at month 12. | 12 months | |
| Secondary | Number of patients who achieved a Immunological Response (IR) at month 12. | 12 months | |
| Secondary | Assessment of time to achieving CR, PR, IR. | 24 months | |
| Secondary | Assessment of time to relapse for patients who achieved CR, PR, IR. | 12 and 24 months | |
| Secondary | Duration of time between initial achievement of CR to latest date of observed remission. | 24 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05696613/registered